Krill Steven L.
EVP & Chief Scientific Officer at EAGLE PHARMACEUTICALS, INC.
- Sold, on record
- $7M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Mar 23, 2017
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- EAGLE PHARMACEUTICALS, INC.EVP & Chief Scientific Officer
Sales by reason
Form 4 sales per year, every sale on record.
Timeline
- 1 Form 4 sale EAGLE PHARMACEUTICALS, INC.UnusualJun 16, 2015 2015
Sold 9,980 shares at $81.60 ($814k)
Krill Steven L., Chief Scientific Officer
Sold 100% of holdings ($814k position)0 shares leftFirst sale on recordFiling
- 2 Form 4 sale EAGLE PHARMACEUTICALS, INC.UnusualNov 30, 2016 +533 days
Sold 5,987 shares at $80.00 ($479k)
Krill Steven L., EVP & Chief Scientific Officer
Sold 100% of holdings ($479k position)0 shares leftFiling
- 3 Form 4 sale EAGLE PHARMACEUTICALS, INC.UnusualDec 13, 2016 +13 days
Sold 10,000 shares at $73.62 ($736k)
Krill Steven L., EVP & Chief Scientific Officer
Sold 100% of holdings ($736k position)0 shares leftFiling
- 4 Form 4 sale EAGLE PHARMACEUTICALS, INC.UnusualDec 23, 2016 +10 days
Sold 50,505 shares at $76.40 ($3.9M)
Krill Steven L., EVP & Chief Scientific Officer
Sold 100% of holdings ($3.9M position)0 shares left5.1x usual sizeFiling
- 5 Form 4 sale EAGLE PHARMACEUTICALS, INC.UnusualMar 23, 2017 +90 days
Sold 14,125 shares at $81.07 ($1.1M)
Krill Steven L., EVP & Chief Scientific Officer
Sold 100% of holdings ($1.1M position)0 shares left1.4x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 23, 2017 | Mar 24, 2017 | EAGLE PHARMACEUTICALS, INC. | EVP & Chief Scientific Officer | Form 4 sale | 14,125 | $1.1M | 100.0% | Unusual | SEC |
| Dec 23, 2016 | Jan 4, 2017 | EAGLE PHARMACEUTICALS, INC. | EVP & Chief Scientific Officer | Form 4 sale | 50,505 | $3.9M | 100.0% | Unusual | SEC |
| Dec 13, 2016 | Dec 15, 2016 | EAGLE PHARMACEUTICALS, INC. | EVP & Chief Scientific Officer | Form 4 sale | 10,000 | $736k | 100.0% | Unusual | SEC |
| Nov 30, 2016 | Dec 2, 2016 | EAGLE PHARMACEUTICALS, INC. | EVP & Chief Scientific Officer | Form 4 sale | 5,987 | $479k | 100.0% | Unusual | SEC |
| Jun 16, 2015 | Jun 18, 2015 | EAGLE PHARMACEUTICALS, INC. | Chief Scientific Officer | Form 4 sale | 9,980 | $814k | 100.0% | Unusual | SEC |